ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Translational Regenerative Medicine Sales Market Report 2021
Published Date: 2021-06-04
|
Report Code: QYRE-Auto-2Z5170
Home | Market Reports
Global Translational Regenerative Medicine Sales Market Report 2021

Global Translational Regenerative Medicine Sales Market Report 2021

Code: QYRE-Auto-2Z5170
Report
2021-06-04
Pages:142
QYResearch
Description
Table of Content
Tables & Figures
The global Translational Regenerative Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Translational Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
 

Segment by Type

  • Stem Cell Therapy
  • Tissue Engineering
  • Gene Therapy
 

Segment by Application

  • Tissue Engineering Therapy
  • Wound Healing
  • Cartilage Repair
  • Other
 
The Translational Regenerative Medicine market is analysed and market size information is provided by regions (countries). Segment by Application, the Translational Regenerative Medicine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
 

BY COMPANY

  • Athersys
  • Avita Medical
  • AxoGen
  • MEDIPOST
  • NuVasive
  • Astellas Pharma
  • Organogenesis Holdings
  • Osiris Therapeutics
  • Pharmicell
  • Regenerys
  • Takeda Pharmaceutical
  • uniQure
  • Vericel
1 Translational Regenerative Medicine Market Overview
1.1 Translational Regenerative Medicine Product Scope
1.2 Translational Regenerative Medicine Segment by Type
1.2.1 Global Translational Regenerative Medicine Sales by Type (2016 & 2021 & 2027)
1.2.2 Stem Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Gene Therapy
1.3 Translational Regenerative Medicine Segment by Application
1.3.1 Global Translational Regenerative Medicine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Tissue Engineering Therapy
1.3.3 Wound Healing
1.3.4 Cartilage Repair
1.3.5 Other
1.4 Translational Regenerative Medicine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Translational Regenerative Medicine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Translational Regenerative Medicine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Translational Regenerative Medicine Price Trends (2016-2027)
2 Translational Regenerative Medicine Estimates and Forecasts by Region
2.1 Global Translational Regenerative Medicine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Translational Regenerative Medicine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Translational Regenerative Medicine Sales Market Share by Region (2016-2021)
2.2.2 Global Translational Regenerative Medicine Revenue Market Share by Region (2016-2021)
2.3 Global Translational Regenerative Medicine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Translational Regenerative Medicine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Translational Regenerative Medicine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Translational Regenerative Medicine Estimates and Projections (2016-2027)
2.4.2 Europe Translational Regenerative Medicine Estimates and Projections (2016-2027)
2.4.3 China Translational Regenerative Medicine Estimates and Projections (2016-2027)
2.4.4 Japan Translational Regenerative Medicine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Translational Regenerative Medicine Estimates and Projections (2016-2027)
2.4.6 India Translational Regenerative Medicine Estimates and Projections (2016-2027)
3 Global Translational Regenerative Medicine Competition Landscape by Players
3.1 Global Top Translational Regenerative Medicine Players by Sales (2016-2021)
3.2 Global Top Translational Regenerative Medicine Players by Revenue (2016-2021)
3.3 Global Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Translational Regenerative Medicine as of 2020)
3.4 Global Translational Regenerative Medicine Average Price by Company (2016-2021)
3.5 Manufacturers Translational Regenerative Medicine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Translational Regenerative Medicine Market Size by Type
4.1 Global Translational Regenerative Medicine Historic Market Review by Type (2016-2021)
4.1.1 Global Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
4.1.2 Global Translational Regenerative Medicine Revenue Market Share by Type (2016-2021)
4.1.3 Global Translational Regenerative Medicine Price by Type (2016-2021)
4.2 Global Translational Regenerative Medicine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Translational Regenerative Medicine Sales Forecast by Type (2022-2027)
4.2.2 Global Translational Regenerative Medicine Revenue Forecast by Type (2022-2027)
4.2.3 Global Translational Regenerative Medicine Price Forecast by Type (2022-2027)
5 Global Translational Regenerative Medicine Market Size by Application
5.1 Global Translational Regenerative Medicine Historic Market Review by Application (2016-2021)
5.1.1 Global Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
5.1.2 Global Translational Regenerative Medicine Revenue Market Share by Application (2016-2021)
5.1.3 Global Translational Regenerative Medicine Price by Application (2016-2021)
5.2 Global Translational Regenerative Medicine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Translational Regenerative Medicine Sales Forecast by Application (2022-2027)
5.2.2 Global Translational Regenerative Medicine Revenue Forecast by Application (2022-2027)
5.2.3 Global Translational Regenerative Medicine Price Forecast by Application (2022-2027)
6 North America Translational Regenerative Medicine Market Facts & Figures
6.1 North America Translational Regenerative Medicine Sales by Company
6.1.1 North America Translational Regenerative Medicine Sales by Company (2016-2021)
6.1.2 North America Translational Regenerative Medicine Revenue by Company (2016-2021)
6.2 North America Translational Regenerative Medicine Sales Breakdown by Type
6.2.1 North America Translational Regenerative Medicine Sales Breakdown by Type (2016-2021)
6.2.2 North America Translational Regenerative Medicine Sales Breakdown by Type (2022-2027)
6.3 North America Translational Regenerative Medicine Sales Breakdown by Application
6.3.1 North America Translational Regenerative Medicine Sales Breakdown by Application (2016-2021)
6.3.2 North America Translational Regenerative Medicine Sales Breakdown by Application (2022-2027)
7 Europe Translational Regenerative Medicine Market Facts & Figures
7.1 Europe Translational Regenerative Medicine Sales by Company
7.1.1 Europe Translational Regenerative Medicine Sales by Company (2016-2021)
7.1.2 Europe Translational Regenerative Medicine Revenue by Company (2016-2021)
7.2 Europe Translational Regenerative Medicine Sales Breakdown by Type
7.2.1 Europe Translational Regenerative Medicine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Translational Regenerative Medicine Sales Breakdown by Type (2022-2027)
7.3 Europe Translational Regenerative Medicine Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Translational Regenerative Medicine Market Facts & Figures
8.1 China Translational Regenerative Medicine Sales by Company
8.1.1 China Translational Regenerative Medicine Sales by Company (2016-2021)
8.1.2 China Translational Regenerative Medicine Revenue by Company (2016-2021)
8.2 China Translational Regenerative Medicine Sales Breakdown by Type
8.2.1 China Translational Regenerative Medicine Sales Breakdown by Type (2016-2021)
8.2.2 China Translational Regenerative Medicine Sales Breakdown by Type (2022-2027)
8.3 China Translational Regenerative Medicine Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Translational Regenerative Medicine Market Facts & Figures
9.1 Japan Translational Regenerative Medicine Sales by Company
9.1.1 Japan Translational Regenerative Medicine Sales by Company (2016-2021)
9.1.2 Japan Translational Regenerative Medicine Revenue by Company (2016-2021)
9.2 Japan Translational Regenerative Medicine Sales Breakdown by Type
9.2.1 Japan Translational Regenerative Medicine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Translational Regenerative Medicine Sales Breakdown by Type (2022-2027)
9.3 Japan Translational Regenerative Medicine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Translational Regenerative Medicine Market Facts & Figures
10.1 Southeast Asia Translational Regenerative Medicine Sales by Company
10.1.1 Southeast Asia Translational Regenerative Medicine Sales by Company (2016-2021)
10.1.2 Southeast Asia Translational Regenerative Medicine Revenue by Company (2016-2021)
10.2 Southeast Asia Translational Regenerative Medicine Sales Breakdown by Type
10.2.1 Southeast Asia Translational Regenerative Medicine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Translational Regenerative Medicine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Translational Regenerative Medicine Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Translational Regenerative Medicine Market Facts & Figures
11.1 India Translational Regenerative Medicine Sales by Company
11.1.1 India Translational Regenerative Medicine Sales by Company (2016-2021)
11.1.2 India Translational Regenerative Medicine Revenue by Company (2016-2021)
11.2 India Translational Regenerative Medicine Sales Breakdown by Type
11.2.1 India Translational Regenerative Medicine Sales Breakdown by Type (2016-2021)
11.2.2 India Translational Regenerative Medicine Sales Breakdown by Type (2022-2027)
11.3 India Translational Regenerative Medicine Sales Breakdown by Application
11.3.1 India Translational Regenerative Medicine Sales Breakdown by Application (2016-2021)
11.3.2 India Translational Regenerative Medicine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Translational Regenerative Medicine Business
12.1 Athersys
12.1.1 Athersys Corporation Information
12.1.2 Athersys Business Overview
12.1.3 Athersys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Athersys Translational Regenerative Medicine Products Offered
12.1.5 Athersys Recent Development
12.2 Avita Medical
12.2.1 Avita Medical Corporation Information
12.2.2 Avita Medical Business Overview
12.2.3 Avita Medical Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Avita Medical Translational Regenerative Medicine Products Offered
12.2.5 Avita Medical Recent Development
12.3 AxoGen
12.3.1 AxoGen Corporation Information
12.3.2 AxoGen Business Overview
12.3.3 AxoGen Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AxoGen Translational Regenerative Medicine Products Offered
12.3.5 AxoGen Recent Development
12.4 MEDIPOST
12.4.1 MEDIPOST Corporation Information
12.4.2 MEDIPOST Business Overview
12.4.3 MEDIPOST Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 MEDIPOST Translational Regenerative Medicine Products Offered
12.4.5 MEDIPOST Recent Development
12.5 NuVasive
12.5.1 NuVasive Corporation Information
12.5.2 NuVasive Business Overview
12.5.3 NuVasive Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 NuVasive Translational Regenerative Medicine Products Offered
12.5.5 NuVasive Recent Development
12.6 Astellas Pharma
12.6.1 Astellas Pharma Corporation Information
12.6.2 Astellas Pharma Business Overview
12.6.3 Astellas Pharma Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Astellas Pharma Translational Regenerative Medicine Products Offered
12.6.5 Astellas Pharma Recent Development
12.7 Organogenesis Holdings
12.7.1 Organogenesis Holdings Corporation Information
12.7.2 Organogenesis Holdings Business Overview
12.7.3 Organogenesis Holdings Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Organogenesis Holdings Translational Regenerative Medicine Products Offered
12.7.5 Organogenesis Holdings Recent Development
12.8 Osiris Therapeutics
12.8.1 Osiris Therapeutics Corporation Information
12.8.2 Osiris Therapeutics Business Overview
12.8.3 Osiris Therapeutics Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Osiris Therapeutics Translational Regenerative Medicine Products Offered
12.8.5 Osiris Therapeutics Recent Development
12.9 Pharmicell
12.9.1 Pharmicell Corporation Information
12.9.2 Pharmicell Business Overview
12.9.3 Pharmicell Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pharmicell Translational Regenerative Medicine Products Offered
12.9.5 Pharmicell Recent Development
12.10 Regenerys
12.10.1 Regenerys Corporation Information
12.10.2 Regenerys Business Overview
12.10.3 Regenerys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Regenerys Translational Regenerative Medicine Products Offered
12.10.5 Regenerys Recent Development
12.11 Takeda Pharmaceutical
12.11.1 Takeda Pharmaceutical Corporation Information
12.11.2 Takeda Pharmaceutical Business Overview
12.11.3 Takeda Pharmaceutical Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Takeda Pharmaceutical Translational Regenerative Medicine Products Offered
12.11.5 Takeda Pharmaceutical Recent Development
12.12 uniQure
12.12.1 uniQure Corporation Information
12.12.2 uniQure Business Overview
12.12.3 uniQure Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 uniQure Translational Regenerative Medicine Products Offered
12.12.5 uniQure Recent Development
12.13 Vericel
12.13.1 Vericel Corporation Information
12.13.2 Vericel Business Overview
12.13.3 Vericel Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Vericel Translational Regenerative Medicine Products Offered
12.13.5 Vericel Recent Development
13 Translational Regenerative Medicine Manufacturing Cost Analysis
13.1 Translational Regenerative Medicine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Translational Regenerative Medicine
13.4 Translational Regenerative Medicine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Translational Regenerative Medicine Distributors List
14.3 Translational Regenerative Medicine Customers
15 Market Dynamics
15.1 Translational Regenerative Medicine Market Trends
15.2 Translational Regenerative Medicine Drivers
15.3 Translational Regenerative Medicine Market Challenges
15.4 Translational Regenerative Medicine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Translational Regenerative Medicine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Translational Regenerative Medicine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Translational Regenerative Medicine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Translational Regenerative Medicine Sales (K Units) by Region (2016-2021)
    Table 5. Global Translational Regenerative Medicine Sales Market Share by Region (2016-2021)
    Table 6. Global Translational Regenerative Medicine Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Translational Regenerative Medicine Revenue Share by Region (2016-2021)
    Table 8. Global Translational Regenerative Medicine Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Translational Regenerative Medicine Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Translational Regenerative Medicine Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Translational Regenerative Medicine Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Translational Regenerative Medicine Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Translational Regenerative Medicine Sales Share by Company (2016-2021)
    Table 14. Global Translational Regenerative Medicine Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Translational Regenerative Medicine Revenue Share by Company (2016-2021)
    Table 16. Global Translational Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Translational Regenerative Medicine as of 2020)
    Table 17. Global Translational Regenerative Medicine Average Price (USD/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Translational Regenerative Medicine Manufacturing Sites and Area Served
    Table 19. Manufacturers Translational Regenerative Medicine Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Translational Regenerative Medicine Sales (K Units) by Type (2016-2021)
    Table 22. Global Translational Regenerative Medicine Sales Share by Type (2016-2021)
    Table 23. Global Translational Regenerative Medicine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Translational Regenerative Medicine Price (USD/Unit) by Type (2016-2021)
    Table 25. Global Translational Regenerative Medicine Sales Share by Type (2022-2027)
    Table 26. Global Translational Regenerative Medicine Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 27. Global Translational Regenerative Medicine Revenue Share by Type (2022-2027)
    Table 28. Global Translational Regenerative Medicine Price (USD/Unit) by Type (2022-2027)
    Table 29. Global Translational Regenerative Medicine Sales (K Units) by Application (2016-2021)
    Table 30. Global Translational Regenerative Medicine Sales Share by Application (2016-2021)
    Table 31. Global Translational Regenerative Medicine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Translational Regenerative Medicine Price (USD/Unit) by Application (2016-2021)
    Table 33. Global Translational Regenerative Medicine Sales (K Units) by Application (2022-2027)
    Table 34. Global Translational Regenerative Medicine Sales Share by Application (2022-2027)
    Table 35. Global Translational Regenerative Medicine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Translational Regenerative Medicine Revenue Share by Application (2022-2027)
    Table 37. Global Translational Regenerative Medicine Price (USD/Unit) by Application (2022-2027)
    Table 38. North America Translational Regenerative Medicine Sales (K Units) by Company (2016-2021)
    Table 39. North America Translational Regenerative Medicine Sales Market Share by Company (2016-2021)
    Table 40. North America Translational Regenerative Medicine Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Translational Regenerative Medicine Revenue Market Share by Company (2016-2021)
    Table 42. North America Translational Regenerative Medicine Sales by Type (2016-2021) & (K Units)
    Table 43. North America Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
    Table 44. North America Translational Regenerative Medicine Sales by Type (2022-2027) & (K Units)
    Table 45. North America Translational Regenerative Medicine Sales Market Share by Type (2022-2027)
    Table 46. North America Translational Regenerative Medicine Sales by Application (2016-2021) & (K Units)
    Table 47. North America Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
    Table 48. North America Translational Regenerative Medicine Sales by Application (2022-2027) & (K Units)
    Table 49. North America Translational Regenerative Medicine Sales Market Share by Application (2022-2027)
    Table 50. Europe Translational Regenerative Medicine Sales (K Units) by Company (2016-2021)
    Table 51. Europe Translational Regenerative Medicine Sales Market Share by Company (2016-2021)
    Table 52. Europe Translational Regenerative Medicine Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Translational Regenerative Medicine Revenue Market Share by Company (2016-2021)
    Table 54. Europe Translational Regenerative Medicine Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
    Table 56. Europe Translational Regenerative Medicine Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Translational Regenerative Medicine Sales Market Share by Type (2022-2027)
    Table 58. Europe Translational Regenerative Medicine Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
    Table 60. Europe Translational Regenerative Medicine Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Translational Regenerative Medicine Sales Market Share by Application (2022-2027)
    Table 62. China Translational Regenerative Medicine Sales (K Units) by Company (2016-2021)
    Table 63. China Translational Regenerative Medicine Sales Market Share by Company (2016-2021)
    Table 64. China Translational Regenerative Medicine Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Translational Regenerative Medicine Revenue Market Share by Company (2016-2021)
    Table 66. China Translational Regenerative Medicine Sales by Type (2016-2021) & (K Units)
    Table 67. China Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
    Table 68. China Translational Regenerative Medicine Sales by Type (2022-2027) & (K Units)
    Table 69. China Translational Regenerative Medicine Sales Market Share by Type (2022-2027)
    Table 70. China Translational Regenerative Medicine Sales by Application (2016-2021) & (K Units)
    Table 71. China Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
    Table 72. China Translational Regenerative Medicine Sales by Application (2022-2027) & (K Units)
    Table 73. China Translational Regenerative Medicine Sales Market Share by Application (2022-2027)
    Table 74. Japan Translational Regenerative Medicine Sales (K Units) by Company (2016-2021)
    Table 75. Japan Translational Regenerative Medicine Sales Market Share by Company (2016-2021)
    Table 76. Japan Translational Regenerative Medicine Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Translational Regenerative Medicine Revenue Market Share by Company (2016-2021)
    Table 78. Japan Translational Regenerative Medicine Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
    Table 80. Japan Translational Regenerative Medicine Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Translational Regenerative Medicine Sales Market Share by Type (2022-2027)
    Table 82. Japan Translational Regenerative Medicine Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
    Table 84. Japan Translational Regenerative Medicine Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Translational Regenerative Medicine Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Translational Regenerative Medicine Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Translational Regenerative Medicine Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Translational Regenerative Medicine Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Translational Regenerative Medicine Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Translational Regenerative Medicine Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Translational Regenerative Medicine Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Translational Regenerative Medicine Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Translational Regenerative Medicine Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Translational Regenerative Medicine Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Translational Regenerative Medicine Sales Market Share by Application (2022-2027)
    Table 98. India Translational Regenerative Medicine Sales (K Units) by Company (2016-2021)
    Table 99. India Translational Regenerative Medicine Sales Market Share by Company (2016-2021)
    Table 100. India Translational Regenerative Medicine Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Translational Regenerative Medicine Revenue Market Share by Company (2016-2021)
    Table 102. India Translational Regenerative Medicine Sales by Type (2016-2021) & (K Units)
    Table 103. India Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
    Table 104. India Translational Regenerative Medicine Sales by Type (2022-2027) & (K Units)
    Table 105. India Translational Regenerative Medicine Sales Market Share by Type (2022-2027)
    Table 106. India Translational Regenerative Medicine Sales by Application (2016-2021) & (K Units)
    Table 107. India Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
    Table 108. India Translational Regenerative Medicine Sales by Application (2022-2027) & (K Units)
    Table 109. India Translational Regenerative Medicine Sales Market Share by Application (2022-2027)
    Table 110. Athersys Corporation Information
    Table 111. Athersys Description and Business Overview
    Table 112. Athersys Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. Athersys Translational Regenerative Medicine Product
    Table 114. Athersys Recent Development
    Table 115. Avita Medical Corporation Information
    Table 116. Avita Medical Description and Business Overview
    Table 117. Avita Medical Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Avita Medical Translational Regenerative Medicine Product
    Table 119. Avita Medical Recent Development
    Table 120. AxoGen Corporation Information
    Table 121. AxoGen Description and Business Overview
    Table 122. AxoGen Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. AxoGen Translational Regenerative Medicine Product
    Table 124. AxoGen Recent Development
    Table 125. MEDIPOST Corporation Information
    Table 126. MEDIPOST Description and Business Overview
    Table 127. MEDIPOST Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. MEDIPOST Translational Regenerative Medicine Product
    Table 129. MEDIPOST Recent Development
    Table 130. NuVasive Corporation Information
    Table 131. NuVasive Description and Business Overview
    Table 132. NuVasive Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. NuVasive Translational Regenerative Medicine Product
    Table 134. NuVasive Recent Development
    Table 135. Astellas Pharma Corporation Information
    Table 136. Astellas Pharma Description and Business Overview
    Table 137. Astellas Pharma Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. Astellas Pharma Translational Regenerative Medicine Product
    Table 139. Astellas Pharma Recent Development
    Table 140. Organogenesis Holdings Corporation Information
    Table 141. Organogenesis Holdings Description and Business Overview
    Table 142. Organogenesis Holdings Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Organogenesis Holdings Translational Regenerative Medicine Product
    Table 144. Organogenesis Holdings Recent Development
    Table 145. Osiris Therapeutics Corporation Information
    Table 146. Osiris Therapeutics Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 147. Osiris Therapeutics Description and Business Overview
    Table 148. Osiris Therapeutics Translational Regenerative Medicine Product
    Table 149. Osiris Therapeutics Recent Development
    Table 150. Pharmicell Corporation Information
    Table 151. Pharmicell Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 152. Pharmicell Description and Business Overview
    Table 153. Pharmicell Translational Regenerative Medicine Product
    Table 154. Pharmicell Recent Development
    Table 155. Regenerys Corporation Information
    Table 156. Regenerys Description and Business Overview
    Table 157. Regenerys Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. Regenerys Translational Regenerative Medicine Product
    Table 159. Regenerys Recent Development
    Table 160. Takeda Pharmaceutical Corporation Information
    Table 161. Takeda Pharmaceutical Description and Business Overview
    Table 162. Takeda Pharmaceutical Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 163. Takeda Pharmaceutical Translational Regenerative Medicine Product
    Table 164. Takeda Pharmaceutical Recent Development
    Table 165. uniQure Corporation Information
    Table 166. uniQure Description and Business Overview
    Table 167. uniQure Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 168. uniQure Translational Regenerative Medicine Product
    Table 169. uniQure Recent Development
    Table 170. Vericel Corporation Information
    Table 171. Vericel Description and Business Overview
    Table 172. Vericel Translational Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 173. Vericel Translational Regenerative Medicine Product
    Table 174. Vericel Recent Development
    Table 175. Production Base and Market Concentration Rate of Raw Material
    Table 176. Key Suppliers of Raw Materials
    Table 177. Translational Regenerative Medicine Distributors List
    Table 178. Translational Regenerative Medicine Customers List
    Table 179. Translational Regenerative Medicine Market Trends
    Table 180. Translational Regenerative Medicine Market Drivers
    Table 181. Translational Regenerative Medicine Market Challenges
    Table 182. Translational Regenerative Medicine Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Translational Regenerative Medicine Product Picture
    Figure 2. Global Translational Regenerative Medicine Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Translational Regenerative Medicine Sales Market Share by Application in 2021 & 2027
    Figure 6. Tissue Engineering Therapy Examples
    Figure 7. Wound Healing Examples
    Figure 8. Cartilage Repair Examples
    Figure 9. Other Examples
    Figure 10. Global Translational Regenerative Medicine Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Translational Regenerative Medicine Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Translational Regenerative Medicine Sales (K Units) Growth Rate (2016-2027)
    Figure 13. Global Translational Regenerative Medicine Price Trends Growth Rate (2016-2027) (USD/Unit)
    Figure 14. Global Translational Regenerative Medicine Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Translational Regenerative Medicine Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Translational Regenerative Medicine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Translational Regenerative Medicine Sales (K Units) Growth Rate (2016-2027)
    Figure 18. Europe Translational Regenerative Medicine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Translational Regenerative Medicine Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Translational Regenerative Medicine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Translational Regenerative Medicine Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Translational Regenerative Medicine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Translational Regenerative Medicine Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Translational Regenerative Medicine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Translational Regenerative Medicine Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Translational Regenerative Medicine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Translational Regenerative Medicine Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Translational Regenerative Medicine Players Market Share by Revenue in Translational Regenerative Medicine: 2016 & 2020
    Figure 29. Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Translational Regenerative Medicine Revenue Share by Type (2016-2021)
    Figure 31. Global Translational Regenerative Medicine Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Translational Regenerative Medicine Revenue Share by Application (2016-2021)
    Figure 33. Global Translational Regenerative Medicine Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Translational Regenerative Medicine Sales Market Share by Type in 2020
    Figure 35. North America Translational Regenerative Medicine Sales Market Share by Application in 2020
    Figure 36. Europe Translational Regenerative Medicine Sales Market Share by Type in 2020
    Figure 37. Europe Translational Regenerative Medicine Sales Market Share by Application in 2020
    Figure 38. China Translational Regenerative Medicine Sales Market Share by Type in 2020
    Figure 39. China Translational Regenerative Medicine Sales Market Share by Application in 2020
    Figure 40. Japan Translational Regenerative Medicine Sales Market Share by Type in 2020
    Figure 41. Japan Translational Regenerative Medicine Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Translational Regenerative Medicine Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Translational Regenerative Medicine Sales Market Share by Application in 2020
    Figure 44. India Translational Regenerative Medicine Sales Market Share by Type in 2020
    Figure 45. India Translational Regenerative Medicine Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Translational Regenerative Medicine
    Figure 48. Manufacturing Process Analysis of Translational Regenerative Medicine
    Figure 49. Translational Regenerative Medicine Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4000

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions